Bayforest Capital’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.1K Buy
467
+159
+52% +$26.5K 0.07% 527
2026
Q1
$64.6K Sell
308
-467
-60% -$117K 0.07% 495
2025
Q4
$220K Sell
775
-639
-45% -$200K 0.16% 252
2025
Q3
$437K Buy
1,414
+376
+36% +$118K 0.21% 175
2025
Q2
$326K Buy
1,038
+430
+71% +$124K 0.14% 283
2025
Q1
$160K Buy
608
+314
+107% +$85K 0.07% 428
2024
Q4
$76.8K Buy
+294
New +$74K 0.1% 377

Other funds holding PODD

Bayforest Capital's PODD Position: Q2 2026 in Review

Bayforest Capital increased its Insulet (PODD) stake by 52% in Q2 2026, buying an estimated $26.5K and bringing the position to 467 shares worth $71.1K. The position accounts for 0.07% of the portfolio, ranked #527.

Bayforest Capital first reported a position in PODD in Q4 2024 and has held it in 7 quarters since. The position peaked at $437K in Q3 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Bayforest Capital held 467 shares of Insulet worth $71.1K as of Q2 2026.
  • Bayforest Capital bought 159 Insulet shares in Q2 2026, an estimated $26.5K.
  • Insulet made up 0.07% of Bayforest Capital's portfolio in Q2 2026, its #527 holding.
  • Bayforest Capital first reported a position in Insulet in Q4 2024 and has held it in 7 quarters since.
  • Bayforest Capital's Insulet position peaked at $437K in Q3 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.